TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.

Song Y, Zhou G, Song E, Zhan L, Wang Q, Song H, Xia J, Cong L

Open source

DOI
10.1155/2022/6235771
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/6235771,
  title = {TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.},
  author = {Song Y and Zhou G and Song E and Zhan L and Wang Q and Song H and Xia J and Cong L},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/6235771},
  url = {https://doi.org/10.1155/2022/6235771}
}

RIS

TY  - JOUR
TI  - TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.
AU  - Song Y
AU  - Zhou G
AU  - Song E
AU  - Zhan L
AU  - Wang Q
AU  - Song H
AU  - Xia J
AU  - Cong L
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/6235771
UR  - https://doi.org/10.1155/2022/6235771
ER  - 

APA

Y, S., G, Z., E, S., L, Z., Q, W., H, S., J, X., & L, C. (2022). TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/6235771

Source records